Surrozen director granted options on 5,550 shares

Surrozen, Inc. director and 10% owner Tim Kutzkey received a grant of stock options covering 5,550 shares of common stock.

Rhea-AI Filing Summary

Surrozen, Inc. director and 10% owner Tim Kutzkey received a grant of stock options covering 5,550 shares of common stock. The options have an exercise price of $30.14 per share and were awarded at no cost as a compensation-related grant.

The options vest and become exercisable on the anniversary of the May 13, 2026 grant date, provided Kutzkey continues serving on Surrozen’s Board of Directors. After this grant, he holds options for 5,550 underlying shares directly, with no other derivative positions shown in this filing.

Insider Trade Summary

Grant/Award: 5,550 shares

Grant/Award 1 txn

Insider Kutzkey Tim

Role Director, 10% Owner

Type	Security	Shares	Price	Value
Grant/Award	Option (right to buy)	5,550	$0.00	$0.00

Holdings After Transaction: Option (right to buy) — 5,550 contracts (Direct)

Footnotes (1)

1. F1. The options vest and become exercisable on the anniversary of the grant date, subject to Reporting Person's continuous service as a member of the Board of Directors of the Issuer.

Key Figures

Options granted: 5,550 options Exercise price: $30.14 per share Shares underlying options: 5,550 shares +3 more

6 metrics

Options granted 5,550 options Covering 5,550 underlying common shares

Exercise price $30.14 per share Exercise price for the option grant

Shares underlying options 5,550 shares Common stock underlying granted options

Vesting condition 1-year service requirement Vests on anniversary of grant if board service continues

Expiration date May 12, 2036 Option expiration date

Holdings after grant 5,550 derivative securities Total options following transaction in this filing

Key Terms

Option (right to buy), Grant, award, or other acquisition, exercise price, expiration date, +1 more

5 terms

Option (right to buy) financial

"security_title: "Option (right to buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

exercise price financial

"conversion_or_exercise_price: "30.1400""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2036-05-12T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

continuous service financial

"subject to Reporting Person's continuous service as a member of the Board"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Surrozen (SRZN) director Tim Kutzkey report?

Tim Kutzkey reported receiving a grant of stock options for 5,550 Surrozen common shares. The options were awarded as compensation, not purchased in the open market, and give him the right to buy shares at a fixed exercise price.

How many Surrozen (SRZN) shares are covered by Kutzkey’s new options?

The option grant covers 5,550 underlying shares of Surrozen common stock. These options represent rights to acquire shares in the future, subject to vesting, rather than an immediate stock purchase or sale in the market.

What is the exercise price of Tim Kutzkey’s Surrozen (SRZN) stock options?

The options have an exercise price of $30.14 per share. This is the fixed price at which Kutzkey can buy Surrozen common stock once the options vest and become exercisable, assuming he remains on the Board.

When do Tim Kutzkey’s Surrozen (SRZN) options vest and become exercisable?

The options vest and become exercisable on the anniversary of the grant date. Vesting is conditioned on Kutzkey’s continuous service as a Surrozen Board member through that date, according to the filing’s footnote.

Is Tim Kutzkey’s Surrozen (SRZN) Form 4 transaction a stock purchase or sale?

The Form 4 reports an option grant classified as a “Grant, award, or other acquisition.” It is not an open-market stock purchase or sale, but a compensation award giving future rights to acquire shares at a set price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 04:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kutzkey Tim

(Last) (First) (Middle)

C/O SURROZEN, INC.

171 OYSTER POINT BLVD., SUITE 400

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Surrozen, Inc./DE [ SRZN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	$30.14	05/13/2026		A		5,550		05/13/2027(1)	05/12/2036	Common Stock	5,550	$0	5,550	D

Explanation of Responses:

1. The options vest and become exercisable on the anniversary of the grant date, subject to Reporting Person's continuous service as a member of the Board of Directors of the Issuer.

Remarks:

This Form 4 is being filed late due to inadvertent administrative error.

	/s/ James Evangelista, as Attorney-in-Fact for Tim Kutzkey	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)